151 related articles for article (PubMed ID: 36785565)
61. Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer.
Pos FJ; Horenblas S; Lebesque J; Moonen L; Schneider C; Sminia P; Bartelink H
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):696-705. PubMed ID: 15183473
[TBL] [Abstract][Full Text] [Related]
62. Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinoma.
Oehler-Jänne C; Seifert B; Lütolf UM; Studer G; Glanzmann C; Ciernik IF
Brachytherapy; 2007; 6(3):218-26. PubMed ID: 17681244
[TBL] [Abstract][Full Text] [Related]
63. Radiation tolerance of rat spinal cord to pulsed dose rate (PDR-) brachytherapy: the impact of differences in temporal dose distribution.
Pop LA; Millar WT; van der Plas M; van der Kogel AJ
Radiother Oncol; 2000 Jun; 55(3):301-15. PubMed ID: 10869745
[TBL] [Abstract][Full Text] [Related]
64. Comparison of liver exposure in CT-guided high-dose rate (HDR) interstitial brachytherapy versus SBRT in hepatocellular carcinoma.
Walter F; Nierer L; Rottler M; Duque AS; Weingandt H; Well J; Shpani R; Landry G; Seidensticker M; Streitparth F; Ricke J; Belka C; Corradini S
Radiat Oncol; 2021 May; 16(1):86. PubMed ID: 33957941
[TBL] [Abstract][Full Text] [Related]
65. Interstitial HDR brachytherapy (HDR-BT) in early stage mobile tongue cancers in young patients - Gliwice experience.
Kellas-Ślęczka S; Białas B; Fijałkowski M; Składowski K; Szlag M; Cholewka A
J Contemp Brachytherapy; 2010 Jun; 2(2):61-63. PubMed ID: 27829846
[TBL] [Abstract][Full Text] [Related]
66. Brachytherapy for Buccal Cancer: From Conventional Low Dose Rate (LDR) or Mold Technique to High Dose Rate Interstitial Brachytherapy (HDR-ISBT).
Kotsuma T; Yamazaki H; Masui K; Yoshida K; Shimizutani K; Akiyama H; Murakami S; Isohashi F; Yoshioka Y; Ogawa K; Tanaka E
Anticancer Res; 2017 Dec; 37(12):6887-6892. PubMed ID: 29187469
[TBL] [Abstract][Full Text] [Related]
67. Interstitial pulsed-dose-rate brachytherapy for the treatment of squamous cell anal carcinoma: A retrospective single institution analysis.
Boukhelif W; Ferri-Molina M; Mazeron R; Maroun P; Duhamel-Oberlander AS; Dumas I; Martinetti F; Guemnie-Tafo A; Chargari C; Haie-Meder C
Brachytherapy; 2015; 14(4):549-53. PubMed ID: 25935731
[TBL] [Abstract][Full Text] [Related]
68. Dosimetric comparison between treatment plans of patients treated with low-dose-rate vs. high-dose-rate interstitial prostate brachytherapy as monotherapy: Initial findings of a randomized clinical trial.
Major T; Polgár C; Jorgo K; Stelczer G; Ágoston P
Brachytherapy; 2017; 16(3):608-615. PubMed ID: 28325472
[TBL] [Abstract][Full Text] [Related]
69. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.
Liu R; Wang X; Tian JH; Yang K; Wang J; Jiang L; Hao XY
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD007563. PubMed ID: 25300170
[TBL] [Abstract][Full Text] [Related]
70. Quality of life up to 10 years after external beam radiotherapy and/or brachytherapy for prostate cancer.
Freiberger C; Berneking V; Vögeli TA; Kirschner-Hermanns R; Eble MJ; Pinkawa M
Brachytherapy; 2018; 17(3):517-523. PubMed ID: 29496423
[TBL] [Abstract][Full Text] [Related]
71. Under-utilisation of high-dose-rate brachytherapy boost in men with intermediate-high risk prostate cancer treated with external beam radiotherapy.
Ong WL; Evans SM; Millar JL
J Med Imaging Radiat Oncol; 2018 Apr; 62(2):256-261. PubMed ID: 29271056
[TBL] [Abstract][Full Text] [Related]
72. Brachytherapy boost (BT-boost) or stereotactic body radiation therapy boost (SBRT-boost) for high-risk prostate cancer (HR-PCa).
Peyraga G; Lizee T; Khalifa J; Blais E; Mauriange-Turpin G; Supiot S; Krhili S; Tremolieres P; Graff-Cailleaud P
Cancer Radiother; 2021 Jun; 25(4):400-409. PubMed ID: 33478838
[TBL] [Abstract][Full Text] [Related]
73. High versus low dose rate intracavitary irradiation for adenocarcinoma of the uterine cervix.
Kim WC; Kim GE; Suh CO; Loh JJ
Jpn J Clin Oncol; 2001 Sep; 31(9):432-7. PubMed ID: 11689597
[TBL] [Abstract][Full Text] [Related]
74. Fractionated high-dose-rate brachytherapy in primary carcinoma of the nasopharynx.
Levendag PC; Schmitz PI; Jansen PP; Eijkenboom WM; Visser AG; Kolkman-Deurloo IK; Sipkema D; Visch LL; Senan S
J Clin Oncol; 1998 Jun; 16(6):2213-20. PubMed ID: 9626223
[TBL] [Abstract][Full Text] [Related]
75. External beam boost versus interstitial high-dose-rate brachytherapy boost in the adjuvant radiotherapy following breast-conserving therapy in early-stage breast cancer: a dosimetric comparison.
Terheyden MM; Melchert C; Kovács G
J Contemp Brachytherapy; 2016 Aug; 8(4):294-300. PubMed ID: 27648082
[TBL] [Abstract][Full Text] [Related]
76. Comparison of the outcome and morbidity for localized or locally advanced prostate cancer treated by high-dose-rate brachytherapy plus external beam radiotherapy (EBRT) versus EBRT alone.
Fang FM; Wang YM; Wang CJ; Huang HY; Chiang PH
Jpn J Clin Oncol; 2008 Jul; 38(7):474-9. PubMed ID: 18621848
[TBL] [Abstract][Full Text] [Related]
77. A high-Z inorganic scintillator-based detector for time-resolved in vivo dosimetry during brachytherapy.
Jørgensen EB; Johansen JG; Overgaard J; Piché-Meunier D; Tho D; Rosales HML; Tanderup K; Beaulieu L; Kertzscher G; Beddar S
Med Phys; 2021 Nov; 48(11):7382-7398. PubMed ID: 34586641
[TBL] [Abstract][Full Text] [Related]
78. Comparison of late toxicity between continuous low-dose-rate and pulsed-dose-rate brachytherapy in cervical cancer patients.
Bachtiary B; Dewitt A; Pintilie M; Jezioranski J; Ahonen S; Levin W; Manchul L; Yeung I; Milosevic M; Fyles A
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1077-82. PubMed ID: 16024181
[TBL] [Abstract][Full Text] [Related]
79. Hypofractionated conformal HDR brachytherapy in hormone naïve men with localized prostate cancer. Is escalation to very high biologically equivalent dose beneficial in all prognostic risk groups?
Galalae RM; Martinez A; Nuernberg N; Edmundson G; Gustafson G; Gonzalez J; Kimming B
Strahlenther Onkol; 2006 Mar; 182(3):135-41. PubMed ID: 16520907
[TBL] [Abstract][Full Text] [Related]
80. High precision radiotherapy including intensity-modulated radiation therapy and pulsed-dose-rate brachytherapy for cervical cancer: a retrospective monoinstitutional study.
Vavassori A; Riva G; Spoto R; Lazzari R; Fodor C; Dicuonzo S; Francia CM; Augugliaro M; Facondo G; Cambria R; Comi S; Cattani F; Botta F; Bagnardi V; Rizzo S; Colombo N; Orecchia R; Jereczek-Fossa BA
J Contemp Brachytherapy; 2019 Dec; 11(6):516-526. PubMed ID: 31969909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
